Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miki Matsui

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Infection Control and Hospital Epidemiology|January 11, 2023
Effect of nasal mupirocin treatment on extranasal carriage of methicillin-resistant <i>Staphylococcus aureus</i> among pediatric patients admitted to the neonatal intensive care unitMiki Matsui, Yoshinori Katayama
Journal of Gastrointestinal and Liver Diseases : JGLD|December 17, 2020
Ca 2+ -Activated K + Channel K Ca 3.1 as a Double-Edged Sword in the Treatment of Inflammatory Bowel DiseaseSusumu Ohya, Miki Matsui, Junko Kajikuri
International Journal of Molecular Sciences|November 14, 2023
Down-Regulation of CYP3A4 by the K<sub>Ca</sub>1.1 Inhibition Is Responsible for Overcoming Resistance to Doxorubicin in Cancer Spheroid ModelsSusumu Ohya, Junko Kajikuri, Hiroaki Kito, et al.
Bioscience, Biotechnology, and Biochemistry|December 7, 2017
First synthesis of (S)-(+)-hymenoic acid, a DNA polymerase λ inhibitor isolated from Hymenochaetaceae spKensuke Takahashi, Miki Matsui, Masaki Kuse, et al.
Bioscience, Biotechnology, and Biochemistry|March 9, 2010
Concise synthesis of an antifeedant sesquiterpene against Locusta migratoriaMiki Matsui, Takuya Tashiro, Mitsuru Sasaki, et al.
Journal of Pharmacological Sciences|December 20, 2021
K<sub>Ca</sub>3.1 inhibition-induced activation of the JNK/c-Jun signaling pathway enhances IL-10 expression in peripherally-induced regulatory T cellsMiki Matsui, Junko Kajikuri, Kyoko Endo, et al.
Cureus|June 1, 2026
Real-Time Estimation of Numerical Rating Scale (NRS) Scores Using Machine Learning-Based Facial Expression Analysis: A Proof-of-Concept StudyKentaro Uejima, Tsutomu Takahashi, Miki Matsui, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2021
Increased Interleukin-10 Expression by the Inhibition of Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel K<sub>Ca</sub>3.1 in CD4<sup>+</sup>CD25<sup>+</sup> Regulatory T Cells in the Recovery Phase in an Inflammatory Bowel Disease Mouse ModelSusumu Ohya, Miki Matsui, Junko Kajikuri, et al.
International Journal of Molecular Sciences|December 24, 2021
K<sub>Ca</sub>1.1 K<sup>+</sup> Channel Inhibition Overcomes Resistance to Antiandrogens and Doxorubicin in a Human Prostate Cancer LNCaP Spheroid ModelSusumu Ohya, Junko Kajikuri, Kyoko Endo, et al.
International Journal of Molecular Sciences|August 12, 2022
Downregulation of IL-8 and IL-10 by the Activation of Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel K<sub>Ca</sub>3.1 in THP-1-Derived M<sub>2</sub> MacrophagesSusumu Ohya, Miki Matsui, Junko Kajikuri, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Infection Control and Hospital Epidemiology|January 11, 2023
Effect of nasal mupirocin treatment on extranasal carriage of methicillin-resistant <i>Staphylococcus aureus</i> among pediatric patients admitted to the neonatal intensive care unitMiki Matsui, Yoshinori Katayama
Journal of Gastrointestinal and Liver Diseases : JGLD|December 17, 2020
Ca 2+ -Activated K + Channel K Ca 3.1 as a Double-Edged Sword in the Treatment of Inflammatory Bowel DiseaseSusumu Ohya, Miki Matsui, Junko Kajikuri
International Journal of Molecular Sciences|November 14, 2023
Down-Regulation of CYP3A4 by the K<sub>Ca</sub>1.1 Inhibition Is Responsible for Overcoming Resistance to Doxorubicin in Cancer Spheroid ModelsSusumu Ohya, Junko Kajikuri, Hiroaki Kito, et al.
Bioscience, Biotechnology, and Biochemistry|December 7, 2017
First synthesis of (S)-(+)-hymenoic acid, a DNA polymerase λ inhibitor isolated from Hymenochaetaceae spKensuke Takahashi, Miki Matsui, Masaki Kuse, et al.
Bioscience, Biotechnology, and Biochemistry|March 9, 2010
Concise synthesis of an antifeedant sesquiterpene against Locusta migratoriaMiki Matsui, Takuya Tashiro, Mitsuru Sasaki, et al.
Journal of Pharmacological Sciences|December 20, 2021
K<sub>Ca</sub>3.1 inhibition-induced activation of the JNK/c-Jun signaling pathway enhances IL-10 expression in peripherally-induced regulatory T cellsMiki Matsui, Junko Kajikuri, Kyoko Endo, et al.
Cureus|June 1, 2026
Real-Time Estimation of Numerical Rating Scale (NRS) Scores Using Machine Learning-Based Facial Expression Analysis: A Proof-of-Concept StudyKentaro Uejima, Tsutomu Takahashi, Miki Matsui, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2021
Increased Interleukin-10 Expression by the Inhibition of Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel K<sub>Ca</sub>3.1 in CD4<sup>+</sup>CD25<sup>+</sup> Regulatory T Cells in the Recovery Phase in an Inflammatory Bowel Disease Mouse ModelSusumu Ohya, Miki Matsui, Junko Kajikuri, et al.
International Journal of Molecular Sciences|December 24, 2021
K<sub>Ca</sub>1.1 K<sup>+</sup> Channel Inhibition Overcomes Resistance to Antiandrogens and Doxorubicin in a Human Prostate Cancer LNCaP Spheroid ModelSusumu Ohya, Junko Kajikuri, Kyoko Endo, et al.
International Journal of Molecular Sciences|August 12, 2022
Downregulation of IL-8 and IL-10 by the Activation of Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel K<sub>Ca</sub>3.1 in THP-1-Derived M<sub>2</sub> MacrophagesSusumu Ohya, Miki Matsui, Junko Kajikuri, et al.
Pageof 5